Amarin Corp Plc (AMRN)

[caddiedad]

Just like CVD isn’t going anywhere, the same is with C-19 and the long hauler effects of the virus. Maybe it’s not AMRN but another company that benefits expanded Vascepa use with beneficial Mitigate data. I’d have a hollow feeling about this stock if Sarissa’s 24M shares weren’t on the table. I find their investment very reassuring going forward. BVF is also most prominent, as well. As they say, follow the money.